Tagovameran expressed SARS-CoV-2 spike glycoprotein antigen (Preprotein)

Approval Year

Substance Class	Protein Created by `admin` on `Wed Apr 02 20:41:59 GMT 2025` Edited by `admin` on `Wed Apr 02 20:41:59 GMT 2025`
Protein Type	PREPROTEIN
Protein Sub Type	VIRAL ENVELOPE PROTEIN
Sequence Origin	VIRAL
Sequence Type	COMPLETE
Record UNII	XN3S6AWX8W
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

Tagovameran expressed SARS-CoV-2 spike glycoprotein, S1 and S2 domains, with prefusion-stabilizing mutations (K981P and V982P), furin-cleavage-inactivating mutations (R677G, R678S, and R680S), and mutations present in the spike glycoproteins of the Omicr

Preferred Name

English

Tagovameran expressed SARS-CoV-2 spike glycoprotein antigen (Preprotein)

Common Name

English

Code System Code Type Description

FDA UNII

XN3S6AWX8W

Created by admin on Wed Apr 02 20:41:59 GMT 2025 , Edited by admin on Wed Apr 02 20:41:59 GMT 2025

PRIMARY

Related Record Type Details